Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones

Multi-resistant pathogenic strains of non-lactose fermenting Escherichia coli (NLF E. coli) are responsible for various intestinal and extraintestinal infections. Although several studies have characterised such strains using conventional methods, they have not been comprehensively studied at the ge...

Full description

Bibliographic Details
Main Authors: Razib Mazumder, Arif Hussain, Jody E. Phelan, Susana Campino, S. M. Arefeen Haider, Araf Mahmud, Dilruba Ahmed, Md Asadulghani, Taane G. Clark, Dinesh Mondal
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.1027494/full
_version_ 1797990350611021824
author Razib Mazumder
Arif Hussain
Jody E. Phelan
Susana Campino
S. M. Arefeen Haider
Araf Mahmud
Dilruba Ahmed
Md Asadulghani
Taane G. Clark
Dinesh Mondal
author_facet Razib Mazumder
Arif Hussain
Jody E. Phelan
Susana Campino
S. M. Arefeen Haider
Araf Mahmud
Dilruba Ahmed
Md Asadulghani
Taane G. Clark
Dinesh Mondal
author_sort Razib Mazumder
collection DOAJ
description Multi-resistant pathogenic strains of non-lactose fermenting Escherichia coli (NLF E. coli) are responsible for various intestinal and extraintestinal infections. Although several studies have characterised such strains using conventional methods, they have not been comprehensively studied at the genomic level. To address this gap, we used whole-genome sequencing (WGS) coupled with detailed microbiological and biochemical testing to investigate 17 NLF E. coli from a diagnostic centre (icddr,b) in Dhaka, Bangladesh. The prevalence of NLF E. coli was 10%, of which 47% (8/17) exhibited multi-drug resistant (MDR) phenotypes. All isolates (17/17) were confirmed as E. coli and could not ferment lactose sugar. WGS data analysis revealed international high-risk clonal lineages. The most prevalent sequence types (STs) were ST131 (23%), ST1193 (18%), ST12 (18%), ST501 (12%), ST167 (6%), ST73 (6%) and ST12 (6%). Phylogenetic analysis corroborated a striking clonal population amongst the studied NLF E. coli isolates. The predominant phylogroup detected was B2 (65%). The blaCTX-M-15 extended-spectrum beta-lactamase gene was present in 53% of isolates (9/17), whilst 64.7% (11/17) isolates were affiliated with pathogenic pathotypes. All extraintestinal pathogenic E. coli pathotypes demonstrated β-hemolysis. Our study underscores the presence of critical pathogens and MDR clones amongst non-lactose fermenting E. coli. We suggest that non-lactose fermenting E. coli be considered equally capable as lactose fermenting forms in causing intestinal and extraintestinal infections. Further, there is a need to undertake systematic, unbiased monitoring of predominant lineages amongst non-lactose fermenting E. coli that would help in better treatment and prevention strategies.
first_indexed 2024-04-11T08:35:05Z
format Article
id doaj.art-03cdd9b0e9a0422f8849ee4ae10444f8
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-11T08:35:05Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-03cdd9b0e9a0422f8849ee4ae10444f82022-12-22T04:34:22ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-11-011310.3389/fmicb.2022.10274941027494Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clonesRazib Mazumder0Arif Hussain1Jody E. Phelan2Susana Campino3S. M. Arefeen Haider4Araf Mahmud5Dilruba Ahmed6Md Asadulghani7Taane G. Clark8Dinesh Mondal9Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshLaboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomLaboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshLaboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshClinical Microbiology and Immunology Laboratory, Laboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshBiosafety and BSL3 Laboratory, Biosafety Office, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomLaboratory Sciences and Services Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, BangladeshMulti-resistant pathogenic strains of non-lactose fermenting Escherichia coli (NLF E. coli) are responsible for various intestinal and extraintestinal infections. Although several studies have characterised such strains using conventional methods, they have not been comprehensively studied at the genomic level. To address this gap, we used whole-genome sequencing (WGS) coupled with detailed microbiological and biochemical testing to investigate 17 NLF E. coli from a diagnostic centre (icddr,b) in Dhaka, Bangladesh. The prevalence of NLF E. coli was 10%, of which 47% (8/17) exhibited multi-drug resistant (MDR) phenotypes. All isolates (17/17) were confirmed as E. coli and could not ferment lactose sugar. WGS data analysis revealed international high-risk clonal lineages. The most prevalent sequence types (STs) were ST131 (23%), ST1193 (18%), ST12 (18%), ST501 (12%), ST167 (6%), ST73 (6%) and ST12 (6%). Phylogenetic analysis corroborated a striking clonal population amongst the studied NLF E. coli isolates. The predominant phylogroup detected was B2 (65%). The blaCTX-M-15 extended-spectrum beta-lactamase gene was present in 53% of isolates (9/17), whilst 64.7% (11/17) isolates were affiliated with pathogenic pathotypes. All extraintestinal pathogenic E. coli pathotypes demonstrated β-hemolysis. Our study underscores the presence of critical pathogens and MDR clones amongst non-lactose fermenting E. coli. We suggest that non-lactose fermenting E. coli be considered equally capable as lactose fermenting forms in causing intestinal and extraintestinal infections. Further, there is a need to undertake systematic, unbiased monitoring of predominant lineages amongst non-lactose fermenting E. coli that would help in better treatment and prevention strategies.https://www.frontiersin.org/articles/10.3389/fmicb.2022.1027494/fullgenomic epidemiologyhigh risk clonecarbapenem resistanceESBL – Escherichia coliST131 and non-ST131 lineagesnon lactose fermenter
spellingShingle Razib Mazumder
Arif Hussain
Jody E. Phelan
Susana Campino
S. M. Arefeen Haider
Araf Mahmud
Dilruba Ahmed
Md Asadulghani
Taane G. Clark
Dinesh Mondal
Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
Frontiers in Microbiology
genomic epidemiology
high risk clone
carbapenem resistance
ESBL – Escherichia coli
ST131 and non-ST131 lineages
non lactose fermenter
title Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
title_full Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
title_fullStr Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
title_full_unstemmed Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
title_short Non-lactose fermenting Escherichia coli: Following in the footsteps of lactose fermenting E. coli high-risk clones
title_sort non lactose fermenting escherichia coli following in the footsteps of lactose fermenting e coli high risk clones
topic genomic epidemiology
high risk clone
carbapenem resistance
ESBL – Escherichia coli
ST131 and non-ST131 lineages
non lactose fermenter
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.1027494/full
work_keys_str_mv AT razibmazumder nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT arifhussain nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT jodyephelan nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT susanacampino nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT smarefeenhaider nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT arafmahmud nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT dilrubaahmed nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT mdasadulghani nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT taanegclark nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones
AT dineshmondal nonlactosefermentingescherichiacolifollowinginthefootstepsoflactosefermentingecolihighriskclones